Shares of Eastman Kodak Co. (KODK) were down 24% in afternoon trading Monday, putting them on track for a third straight double-digit percentage decline, after the digital printing and film company, which is getting into the pharmaceutical-ingredients business, disclosed that holders of convertible notes were exercising their right to convert those notes into common stock. The stock has now dropped 50% since skyrocketing sixteenfold in three days to $33.20 on July 29, after the Trump administration announced on July 28 that Kodak had received a $765 million loan ( ) as part of a Defense Production Act directive to loosen the reliance on foreign sources for pharmaceutical ingredients. In an 8-K filing with the Securities and Exchange Commission ( ) on Monday, Kodak said the holders of the 5.00% convertible notes due 2021, which were issued in May 2019, are converted a total of $95 million of the notes into 29.9 million shares of Kodak common stock, on July 29. That would imply a value of $3.175 per converted share, while the stock was currently trading at $16.58. On July 27, Kodak granted Chief Executive James Continenza options to buy Kodak stock at various strike prices, which are now all in the money, to "protect" him from dilution ( ) of his share holdings, in case the convertible debt issued in May 2019 were converted into stock. Kodak's stock has now rallied nearly fourfold (up 256.6%) year to date, while the S&P 500 has gained 2.0%.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
August 03, 2020 13:23 ET (17:23 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.